So far, the Haryana health authorities have halted all production at Sonipat-based Maiden pharmaceuticals on the grounds of deficiencies found during a joint inspection by central drug regulatory authority and Food and Drug Administration (FDA), Haryana.from Industry-Economic Times
Read The Rest:economictimes...
